‘It transformed me’: Donna Brazile reflects on ‘constant…

Outgoing Democratic National Committee chair Donna Brazile, in some of her first public comments since the presidential election, opened up Friday about how Russian hacking of the DNC last year colored not only the outcome of the election but also her personal experience in politics. In an interview with Business Insider at the DNC winter meeting on Friday, the chair reflected on the effects of the release of hacked emails from the committee and Hillary Clinton’s campaign chairman that were published by WikiLeaks last year.

Marathon CEO Placed Steep Price Hikes on Drugs Before Emflaza

The CEO of the latest drugmaker to face criticism over a product’s high price has a history of steep hikes on other drugs and at past companies. Marathon Pharmaceuticals LLC Chief Executive Officer Jeffrey Aronin, under fire for setting an $89,000 price on the company’s drug for a rare, deadly muscle disease, was questioned in a letter more than two years ago by Washington lawmakers about mark-ups on two heart drugs.

Free tuition Q&A: Could New York’s plan spread across US?

New York Gov. Andrew Cuomo, right and Vermont Sen. Bernie Sanders wave at the audience as they arrive onstage at an event at LaGuardia Community College, Tuesday, Jan. 3, 2017, in New York. Gov. Cuomo announced a proposal for free tuition at state colleges to hundreds of thousands of low- and middle income residents.

Mylan, Teva Led Peers in – Anomalous’ Price Moves, Study Says

About one in 19 generic drugs sold in the U.S. during the past three years have undergone major price hikes that may be consistent with collusion, according to a wide-ranging study that comes in the middle of a sprawling Justice Department investigation into pharmaceutical price-fixing. Fideres Partners LLP, a London-based consultancy that works with law firms to bring litigation against companies, reported “anomalous pricing patterns” in scores of generic drugs sold in the U.S. from 2013 to 2016.